Arrowhead Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 16.18 M | $304.15 M | 2.16% | 12.96% |
| VANGUARD GROUP INC | 02/11/2025 | 12.18 M | $229.06 M | -0.37% | 10.17% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 11.11 M | $208.89 M | 25.00% | 9.28% |
| STATE STREET CORP | 02/14/2025 | 6.02 M | $113.11 M | -5.32% | 4.82% |
| SLATE PATH CAPITAL LP | 02/14/2025 | 5.23 M | $98.36 M | 7.10% | 4.37% |
| FMR LLC | 02/13/2025 | 5.10 M | $95.90 M | -15.93% | 4.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.95 M | $55.57 M | -0.31% | 2.47% |
| SIREN, L.L.C. | 02/14/2025 | 2.90 M | $54.55 M | 18.01% | 2.42% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 2.51 M | $47.14 M | -29.86% | 2.09% |
| NORGES BANK | 02/12/2025 | 2.05 M | $38.62 M | 100.00% | 1.72% |
| JPMORGAN CHASE & CO | 02/12/2025 | 2.02 M | $37.98 M | -5.96% | 1.69% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 2.01 M | $37.79 M | -6.69% | 1.68% |
| UBS GROUP AG | 02/14/2025 | 1.31 M | $24.54 M | 195.65% | 1.09% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.29 M | $24.33 M | 1.67% | 1.08% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.02 M | $19.13 M | 1.07% | 0.82% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 914,550 | $17.19 M | 41.66% | 0.76% |
| WOODLINE PARTNERS LP | 02/14/2025 | 840,174 | $15.80 M | -2.96% | 0.70% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 830,058 | $15.61 M | -4.19% | 0.69% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 794,373 | $14.93 M | 281.34% | 0.66% |
| WESTERN FINANCIAL CORP/CA | 01/24/2025 | 820,239 | $15.42 M | 0.00% | 0.66% |
| AQUILO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 707,589 | $13.30 M | -11.09% | 0.59% |
| JANE STREET GROUP, LLC | 02/14/2025 | 656,256 | $12.34 M | 41.47% | 0.55% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 632,214 | $11.89 M | 63.07% | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 628,800 | $11.82 M | 100.00% | 0.52% |
| ABRDN PLC | 01/24/2025 | 450,075 | $8.46 M | 12.20% | 0.36% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 430,700 | $8.10 M | 330.70% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 418,246 | $7.86 M | 45.59% | 0.35% |
| RHUMBLINE ADVISERS | 01/30/2025 | 380,344 | $7.15 M | 2.12% | 0.32% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 372,749 | $7.01 M | 265.97% | 0.31% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 380,586 | $7.16 M | 14.17% | 0.30% |
| CENTERBOOK PARTNERS LP | 02/13/2025 | 350,473 | $6.59 M | -11.18% | 0.29% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 332,749 | $6.26 M | -0.77% | 0.28% |
| HOUND PARTNERS, LLC | 02/14/2025 | 325,525 | $6.12 M | -14.04% | 0.27% |
| BARCLAYS PLC | 02/13/2025 | 312,560 | $5.88 M | 13.00% | 0.26% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 300,000 | $5.64 M | -7.69% | 0.25% |
| PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 288,884 | $5.43 M | -0.73% | 0.24% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 02/14/2025 | 280,511 | $5.27 M | 24.73% | 0.22% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 265,482 | $4.99 M | -0.17% | 0.22% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 275,000 | $5.17 M | 100.00% | 0.22% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 258,964 | $4.87 M | 17.03% | 0.22% |
| JOHNSON & JOHNSON | 02/13/2025 | 247,598 | $4.65 M | 0.00% | 0.21% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 245,272 | $4.61 M | -3.68% | 0.20% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 242,702 | $4.56 M | 15.87% | 0.20% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 230,257 | $4.33 M | -35.14% | 0.19% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 224,988 | $4.23 M | 2.61% | 0.19% |
| SWISS NATIONAL BANK | 02/10/2025 | 220,000 | $4.14 M | 0.78% | 0.18% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 205,000 | $3.85 M | 720.00% | 0.17% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 206,070 | $3.83 M | -1.19% | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 197,550 | $3.71 M | 100.00% | 0.16% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 199,154 | $3.74 M | -5.13% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arrowhead Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 376 institutional investors and hedge funds held shares of Arrowhead Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 16.18 M
VANGUARD GROUP INC: 12.18 M
Avoro Capital Advisors LLC: 11.11 M
STATE STREET CORP: 6.02 M
Slate Path Capital LP: 5.23 M
FMR LLC: 5.1 M
79.93% of Arrowhead Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 137.16 M shares in the last 24 months. This purchase volume represents approximately $2.67 B in transactions.